Category: Analyst Research

The share price of Regis Healthcare Ltd (REG) saw a marginal decline of -1.7% after the company reported FY18 revenue of $594.4m and normalized EBITDA of $117.1m, which came in below consensus estimate of $603.3m and $119.9m respectively.

NEXTDC Ltd (NXT) reported solid FY18 results, which saw revenue up +30% to $161.5m and the strong operating leverage saw underlying EBITDA increase by +28% to $62.6, both figures surpassing guidance ranges of $152 – 158m and $58 – 62m respectively.

Perpetual Ltd (PPT) delivered solid results in FY18, with NPAT of $140.2m (up +2%) which was in line with consensus estimates, lifting the stock price marginally by +3.6%.

RHC reported FY18 results in line with its pre-announced disappointing June 2018 trading update where the Company revised guidance.

Afterpay Touch Group (APT) FY18 results were largely well understood by the market given the business updates leading into the results

Caltex Australia’s (CTX) first half FY18 (1H18) results were in line with guidance, with RCOP (replacement cost operating profit) of $296m (+1% on pcp). Total Group revenue was up +19.5% at $21.4bn, while underlying replacement cost EBIT grew +15.0% to $935m, Lytton Refinery the key delta driver ($103m incremental EBIT).

Orocobre (ORE) posted solid numbers which beat more than half of analysts’ estimates at the net income and EPS line, largely driven by strong results from increasing contract lithium prices coupled

Japara Healthcare (JHC) reported a weak FY18 result, below guidance provided in February 2018. Group revenue was up +3.0% on pcp to $373.2m as occupancy hits were offset by contributions

BAL reported solid FY18 results which signalled that operations are turning around fortunes (achieving strong growth in revenue, earnings and cashflow). g a significantly stronger second half relative to the first.

Qube Holdings (QUB) reported a solid FY18 result, in our view, with underlying revenue up +9.1%, underlying operating earnings (EBITDA) up +3.6%,

Boral Ltd (BLD) share price was up +10.1% after BLD announced strong FY18 results, with revenue up +34%, EBITDA up +47% and underlying NPAT up +37.9% driven by full period contribution from the acquired Headwaters business and strong operating results from core business Boral Australia.

MYX’s FY18 result came in ahead of market expectations at the earnings line, with the Company enjoying a significantly stronger second half relative to the first.